Title: Preparation, Characterization, In-Vitro Drug Release and Kinetics Studies Canagliflozin Polymeric Nanopartciles
Authors: Abiramee Ravi, Anusha Ponnusamy, Kirthika Krishnamoorthy
DOI: https://dx.doi.org/10.18535/jmscr/v9i6.35
Abstract
Nanosuspension is one of the most promising approaches for the enhancement of oral bio-availability of poorly soluble drugs. In this current research work, 13 different formulations of surfactant-stabilized nanosuspension of canagliflozin polymeric nanoparticles were developed and optimized based on average particle size distribution, entrapment efficiency, and zeta potential. In-vitro drug release and kinetics experiments were also investigated. The nanoparticle formulation CGF-12 was found with optimum results in particle size distribution and zeta potential analysis. The %EE of drug in the prepared nanosuspension was in the range of 49.5 ± 0.70 to 100 ± 2. In in-vitro drug release studies, CGF-12 formulation showed maximum drug release of 100% in distilled water within 3 hours, 93% in HCl media at the end of 8 hours and reached 100% in phosphate buffer media within 2 hours. Hence, the formulated canagliflozin polymeric nanoparticles are good choice to improve physicochemical properties of the drug and these formulations improve canagliflozin drug efficacy.
Keywords: Canagliflozin, Nanosuspension, Physicochemical, Drug release and Drug kinetics.
References
- Chan D M, Global report on diabetes, World Heal. Organ, 2014; 58 (12): 1–88.
- KesharwaniP et al., Nanotechnology based approaches for anti-diabetic drugsdelivery, Diabetes Res. Clin. Pract., 2018, 136: 52–77.
- FatemiI, Delrobaee F, Bahmani M, Shamsizadeh A, and Allahtavakoli M, Theeffect of the anti-diabetic drug metformin on behavioral manifestations associated with ovariectomy in mice, Lett., 2019, 690: 95–98.
- Moncada R, Landecho M F, and Frühbeck G, Metabolic Surgery Enters the T2DM Treatment Algorithm, Trends Endocrinol. Metab., 2016, 27(10): 678–680.
- Nomura S, Tanabe M and Corporation P, 8.14 Canagliflozin, 2017, 8.
- Information P, PRODUCT INFORMATION Mechanism of Action, 160826: 1–
- Ye L, Miao M,Li S, and Hao K, Nanosuspensions of a new compound , ER- β 005, for enhanced oral bioavailability and improved analgesic efficacy, J. Pharm., 2017, 531 (1): 246–256.
- Kumar M, Pooja D,Gora H, and Gunukula A, Phytomedicine Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability, Phytomedicine, 2018, 40: 48–54.
- Froelich A, Osmałek T,Kunstman P, Jadach B, Brzostowska M, andBiałas W, Design and study of poloxamer-based microemulsion gels with naproxen, Colloids Surfaces A Physicochem. Eng. Asp., 2019, 562: 101–112.
- Wang Y, Wang C,Zhao J,Ding Y, and Li L, Journal of Colloid and InterfaceScience A cost-effective method to prepare curcumin nanosuspensions with enhanced oral bioavailability, Colloid Interface Sci., 2017, 485: 91–98.
- Fattahi A, Ghiasi M, Mohammadi P, Hosseinzadeh L, Adibkia K and Mohammadi G, Preparation and physicochemical characterization of prazosin conjugated PLGA nanoparticles for drug delivery of flutamide, Brazilian Journal of Pharmaceutical Sciences, 2018, 54(4): 1-10.
- Nimesh S, Manchanda R, Kumar R, Saxena A, Chaudhary P, Yadav V, Mozumdar S, Chandra R, Preparation, characterization and in vitro drug release studies of novel polymeric nanoparticles, International Journal of Pharmaceutics, 2006, 323: 146-152.
- Chen P,WangH, He M, Chen B,Yang B, andHu B, Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells, Environ. Saf., 2018, 171: 337–346.
- Güncüm E, Işıklan N, Anlaş C, Ünal N, E & Bakırel T, Development and characterization of polymeric-based nanoparticles for sustained release of amoxicillin – an antimicrobial drug, Artificial Cells, Nanomedicine and Biotechnology- An international journal, 2018, 46: 96